Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy

Abstract Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker, Pan-Immune-Inflammation-Value (PIV) integrates different peripheral blood cell subpopulations. This retrospective study of collected d...

Full description

Bibliographic Details

Main Authors:	Ahmet Bilgehan Şahin, Erdem Cubukcu, Birol Ocak, Adem Deligonul, Sibel Oyucu Orhan, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz, Sibel Cetintas, Gorkem Yarbas, Kazım Senol, Mehmet Refik Goktug, Zeki Burak Yanasma, Ulviyya Hasanzade, Turkkan Evrensel
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/7b6143d575cd46e1a0f433bfca8c57dc
Tags:	Add Tag No Tags, Be the first to tag this record!